Biothera Pharmaceutical Inc. Announces Board Of Directors

GAN, Minn.--(BUSINESS WIRE)--Biothera Holding Corp. today announced the election of the board of directors for Biothera Pharmaceutical Inc., a wholly owned subsidiary that is developing a clinical stage cancer immunotherapy drug.

The 10 directors are Brent Ahrens, Dr. Alex Giaquinto, Mike Grey, Dr. Annalisa Jenkins, Steven Karel, Andrew LaFrence, Richard Mueller, Walter Ogier, Dr. Bruno Osterwalder and Dr. Dwight Porter.

Help employers find you! Check out all the jobs and post your resume.

Back to news